Treace Medical Concepts, Inc.

Treace Medical Concepts, Inc.

$5
-0.63 (-11.19%)
NASDAQ
USD, US
Medical - Devices

52 Week Range

3.92-27.7

Beta

0.37

Market Cap

$310.04M

Last Dividend

0

PE (TTM)

-5.64

Dividend Yield (TTM)

0

Price Chart

Industry

Medical - Devices

Sector

Healthcare

CEO

Mr. John T. Treace

Full-Time Employees

516

IPO Date

2021-04-23

Description

Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement. The company also provides Lapiplasty Mini-Incision precision system. In addition, it offers products to address ancillary surgical procedures, including akin osteotomies, weil osteotomies, intercuneiform stabilization, lesser tarsometatarsal joint fusions, and autograft bone harvesting, as well as for MTP fusion. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra Beach, Florida.

Phone

904 373 5940

Address

203 Fort Wade Road, Ponte Vedra, FL, 32081, US

CIK

0001630627